Oriel Therapeutics' Series C Round

Oriel Therapeutics raised a round of funding on October 09, 2007. Investors include New Leaf Venture Partners.

Oriel Therapeutics is a respiratory drug delivery company developing dry powder delivery systems for the treatment of asthma and COPD.…

Articles about Oriel Therapeutics' Series C Round: